Legal Advantage Investments’s Zimmer Biomet ZBH Stock Holding History

Legal Advantage Investments’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,860	Closed	-$808K	–	99
2025 Q2	$808K	Hold	8,860	–	–	0.38%	59
2025 Q1	$1M	Sell	8,860 -300	-3%	-$32.1K	0.54%	48
2024 Q4	$968K	Sell	9,160 -400	-4%	-$42.9K	0.51%	49
2024 Q3	$1.03M	Sell	9,560 -179	-2%	-$19.5K	0.57%	51
2024 Q2	$1.06M	Hold	9,739	–	–	0.61%	47
2024 Q1	$1.29M	Hold	9,739	–	–	0.72%	41
2023 Q4	$1.19M	Hold	9,739	–	–	0.71%	41
2023 Q3	$1.09M	Hold	9,739	–	–	0.78%	38
2023 Q2	$1.42M	Hold	9,739	–	–	0.95%	31
2023 Q1	$1.26M	Hold	9,739	–	–	0.92%	31
2022 Q4	$1.24M	Buy	9,739 +1	+0%	+$116	1.02%	28
2022 Q3	$1.02M	Hold	9,738	–	–	0.95%	32
2022 Q2	$1.02M	Hold	9,738	–	–	1%	31
2022 Q1	$1.25M	Sell	9,738 -291	-3%	-$35.1K	0.94%	35
2021 Q4	$1.24M	Sell	10,029 -180	-2%	-$23.6K	0.84%	41
2021 Q3	$1.45M	Hold	10,209	–	–	0.97%	35
2021 Q2	$1.59M	Buy	10,209 +1	+0%	+$162	1.09%	30
2021 Q1	$1.59M	Buy	10,208 +217	+2%	+$33.6K	1.19%	29
2020 Q4	$1.5M	Buy	+9,991	New	+$1.41M	1.16%	27

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Legal Advantage Investments's ZBH Position: Q3 2025 in Review

Legal Advantage Investments sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 8,860 shares — an estimated $808K sold.

Legal Advantage Investments first reported a position in ZBH in Q4 2020 and held it in 19 quarters. The position peaked at $1.59M in Q2 2021. 968 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

Legal Advantage Investments reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
Legal Advantage Investments sold 8,860 Zimmer Biomet shares in Q3 2025, an estimated $808K.
Legal Advantage Investments first reported a position in Zimmer Biomet in Q4 2020 and held it in 19 quarters.
Legal Advantage Investments's Zimmer Biomet position peaked at $1.59M in Q2 2021.
968 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Legal Advantage Investments's 13F filing for Q3 2025, filed 20 Oct 2025.